Syra Health Corp. SYRA
$0.91
$0.022.25%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 493.40% | 151.03% | 73.31% | 45.89% | 95.43% |
| Total Depreciation and Amortization | -47.09% | -83.82% | 102.57% | -199.83% | 43.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 64.29% | -34.37% | -84.52% | 2,493.94% | -230.72% |
| Change in Net Operating Assets | -2,652.22% | 86.43% | -179.04% | 22.85% | 81.58% |
| Cash from Operations | -891.45% | 760.87% | -34.70% | 40.89% | 95.18% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 28.88% | 30.17% | 16.95% | 17.06% | 16.77% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 28.88% | 13.79% | 16.95% | -105.61% | 16.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -332.38% | 1,273.53% | -19.76% | -129.86% | 88.76% |